Literature DB >> 7002253

Time of day of taking immunosuppressive agents after renal transplantation: a possible influence on graft survival.

M S Knapp, N P Byrom, R Pownall, P Mayor.   

Abstract

Large-amplitude circadian rhythms in immune responses and the known variations in the effects of glucocorticoids with the time of day of administration suggest that immunosuppressive regimens may need to take this variable into account. In two similar groups of patients with renal transplants functioning satisfactorily after three months subsequent graft failure developed in 66% of those taking all immunosuppressives in the evening, compared with only 22% of those taking immunosuppressives twice daily (p < 0.05). A survey of other transplant units showed that one unit with outstanding results--graft survival at three years 82%--had a unique policy of morning-only administration of immunosuppressives. Doctors need to consider more carefully the time of drug administration when prescribing, as it may be possible to obtain better results with less toxicity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002253      PMCID: PMC1715051          DOI: 10.1136/bmj.281.6252.1382

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  20 in total

1.  Survival and cure of leukemic mice after circadian optimization of treatment with cyclophosphamide and 1-beta-D-arabinofuranosylcytosine.

Authors:  L E Scheving; E R Burns; J E Pauly; F Halberg; E Haus
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

Review 2.  Toward a chronotherapy of neoplasia: tolerance of treatment depends upon host rhythms.

Authors:  F Halberg; E Haus; S S Cardoso; L E Scheving; J F Kühl; R Shiotsuka; G Rosene; J E Pauly; W Runge; J F Spalding; J K Lee; R A Good
Journal:  Experientia       Date:  1973-08-15

3.  Immunosuppression for kidney transplantation.

Authors:  M G McGeown
Journal:  Lancet       Date:  1973-08-11       Impact factor: 79.321

4.  Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone.

Authors:  P R Bell; J D Briggs; K C Calman; A M Paton; R F Wood; S G Macpherson; K Kyle
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

5.  High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection.

Authors:  M M Mussche; S M Ringoir; N N Lameire
Journal:  Nephron       Date:  1976       Impact factor: 2.847

6.  Circadian variation in an immune response in man.

Authors:  J R Cove-Smith; P Kabler; R Pownall; M S Knapp
Journal:  Br Med J       Date:  1978-07-22

7.  Monitoring the function of renal transplants.

Authors:  M S Knapp; R Blamey; R Cove-Smith; M Health
Journal:  Lancet       Date:  1977-12-03       Impact factor: 79.321

8.  One hundred kidney transplants in the Belfast city hospital.

Authors:  M G McGeown; J A Kennedy; W G Loughridge; J Douglas; J A Alexander; S D Clarke; J McEvoy; J C Hewitt
Journal:  Lancet       Date:  1977-09-24       Impact factor: 79.321

9.  Association of postmedication hypocortisolism with early first relapse of idiopathic nephrotic syndrome.

Authors:  S Leisti; N Hallman; O Koskimies; J Perheentupa; J Rapola; J Vilska
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321

10.  Circadian rhythmicity of delayed hypersensitivity to oxazolone in the rat.

Authors:  R Pownall; M S Knapp
Journal:  Clin Sci Mol Med       Date:  1978-04
View more
  3 in total

1.  Influence of the time of administration of dexamethasone 0.25 mg on cortisol secretion in normal humans.

Authors:  P Schulz; C Costa; J Widmer; P Dick
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Steroids and modern immunosuppression.

Authors:  J R Salaman
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

3.  Azathioprine dosage schedule and rejection episodes in renal transplant recipients.

Authors:  L Lennard; C B Brown; M Fox; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.